Article
Enhanced Complement Expression in the Tumor Microenvironment Following Neoadjuvant Therapy: Implications for Immunomodulation and Survival in Pancreatic Ductal Adenocarcinoma
2024-05-13
Abstract excerpt
<title>Abstract</title> <p>Background Neoadjuvant therapy (NAT) is increasingly being used for pancreatic ductal adenocarcinoma (PDAC) treatment. However, its specific effects on carcinoma cells and the tumor microenvironment (TME) are not fully understood. This study aims to investigate how NAT differentially impacts PDAC’s carcinoma cells and TME. Methods Spatial transcriptomics was used to compare gene express...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f31f7917-b0e8-509e-9fef-8f533eeae331
- DOI
- 10.21203/rs.3.rs-4104258/v1
